Research area
Phase 1 Melanoma trials
Melanoma is a form of skin cancer, and research into it examines investigational immunotherapies, targeted medications, and combinations. If you are looking into a study for yourself or for a person in your care, we at Phase 1 Cancer Trials can help work out if one might be suitable.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Phase 1 melanoma studies in numbers
- Phase 1 melanoma studies recruiting in the U.S.
- 106
- states with a study site
- 32
- studies that accept healthy volunteers
- 1
Source: ClinicalTrials.gov. Data processed .
Find Phase 1 melanoma studies by state
These states have the most studies recruiting right now.
Texas
17 studies recruiting.
California
16 studies recruiting.
Pennsylvania
16 studies recruiting.
New York
14 studies recruiting.
Tennessee
12 studies recruiting.
Colorado
9 studies recruiting.
Phase 1 melanoma studies recruiting now
As of November 17, 2026, 106 Phase 1 melanoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.
What they test
- medications81
- biologics such as vaccines or antibodies38
- procedures9
- devices5
- combination products3
A study can test more than one.
Main purpose
- treating a condition102
- supportive care2
- diagnosis1
- other purposes1
Phase
- Early Phase 15
- Phase 149
- Phase 1/252
Who runs them
- industry61
- university, hospital or other42
- government3
Who they enroll
- adults (18 to 64)105
- older adults (65 and over)101
- children (under 18)6
1 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 106 studies.
Recently updated Phase 1 melanoma studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Aurora, CO · Boston, MA · Chicago, IL · and 4 more U.S. locations
- Registry record
- NCT02332668 · updated
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Outpace Bio, Inc.
- Recruiting in
- Atlanta, GA · Detroit, MI · Houston, TX · and 2 more U.S. locations
- Registry record
- NCT07664735 · updated
Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)
- Phase 1
- Ages 3 to 25
- All sexes
- Sponsor
- Children's National Research Institute
- Recruiting in
- Washington D.C., DC
- Registry record
- NCT07796061 · updated
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Recruiting in
- Durham, NC
- Registry record
- NCT05077137 · updated
IL-17 Blockade to Decrease irAEs (REPLAY)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Recruiting in
- Durham, NC
- Registry record
- NCT07237594 · updated
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Recruiting in
- Aurora, CO · Boston, MA · Fairfax, VA · and 5 more U.S. locations
- Registry record
- NCT07584226 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.
What melanoma studies look at
Melanoma is a form of skin cancer. Studies in this area examine immunotherapies, targeted medications, and combinations, all of them investigational. A study is designed to answer one particular question, so what a melanoma trial asks of you changes from one study to the next.
When something is under test in a study, we call it investigational. Researchers do not yet have the full picture of its risks or of how well it works. The study exists to build that picture.
Who may be able to take part
Requirements are set study by study. Your age may count. So may the medications you currently take, your past health, and the effect the cancer has on you. There are also studies that enroll people without the condition.
Working out eligibility is not your job. During a screening visit, the study team does the checking for you. Our guide explains how screening and eligibility work.
What taking part usually involves
A first conversation
The first step in a Phase 1 melanoma trial is hearing about it. A study coordinator describes the trial in general terms and answers what you ask. That comes ahead of everything else.
Informed consent
The study team writes out the complete details for you, known risks among them. Whether you agree is yours to decide.
Screening
Screening is a set of tests and questions about your health. The results tell you and the team if the study is suitable. Being screened does not always lead to taking part.
Study visits
Joining a Phase 1 melanoma trial means coming in for scheduled appointments. The study team uses each one to follow how your health is doing. Leaving is your choice, and you can make it at any point in the study.
Questions about Phase 1 melanoma studies
Do I need a diagnosis to join a study about melanoma?
There is no single answer, because studies differ. A confirmed diagnosis is asked for in some. In others, the assessment is done during screening. Which of these applies is something the study team will explain to you.
Would I have to change the care I receive now?
No part of your care should be altered by you alone. Continuing current care is permitted in certain studies and not permitted in others. This is something the study doctor will review with you. Your own doctor can talk it through with you too, ahead of any decision.
Is there a cost to take part?
As a rule, there is no cost to participants for the study medication, the study tests, or the study visits. You can learn more about costs in our participant guide.
Ask about Phase 1 melanoma studies
It takes a few details from you, and then a coordinator gets in touch. Asking about a Phase 1 cancer trial places you under no obligation.
Independent information
- Skin Cancer (Including Melanoma) — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)